ArticleClinical ophthalmology (Auckland, N.Z.)2025
Clinical Outcomes and in vivo Aberrometry Following the Implantation of a Monofocal IOL with Positive Asphericity.
Article in Clinical ophthalmology (Auckland, N.Z.), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
4 citing papers in PubMed.
- Clinical and refractive outcomes of bilateral enhanced monofocal intraocular lens implantation with targeted mini-monovision.BMC ophthalmology · 2026Article
- Adaptive-Optics-Based Simulation of Astigmatism Effects on Visual Acuity with Enhanced Monofocal Intraocular Lenses.Ophthalmic & physiological optics : the journal of the British College of Ophthalmic Opticians (Optometrists) · 2026Observational
- Clinical Performance of an Enhanced Monofocal IOL Bilaterally Implanted in Patients Targeted for Monovision: A Prospective Study.Journal of clinical medicine · 2026Article
- Visual, Refractive, and Patient-Reported Outcomes Following Bilateral Implantation of an Enhanced Monofocal IOL: An Exploratory Comparison of Achieved Mini-Monovision and Bilateral Emmetropia.Clinical ophthalmology (Auckland, N.Z.) · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Purpose: To evaluate ocular aberrations, visual and refractive outcomes in eyes implanted with a monofocal intraocular lens (IOL) with a positive asphericity profile. Patients and Methods: This prospective observational study included 42 eyes (27 patients) that underwent routine cataract surgery and implantation of RayOne EMV monofocal aspheric IOL. PentacamWave was used to assess corneal (at 4.5 and 6.0-mm diameter) and total ocular wavefront aberrations (at 3.0, 3.5, 4.0, and 4.5-mm pupil). Postoperative assessments between 1 and 3 months included manifest and automated refraction, uncorrected and corrected distance visual acuity (UDVA, CDVA), and distance-corrected intermediate and near visual acuity (DCIVA, DCNVA). Results: Postoperatively, UDVA was 0.06 logMAR, with 100% eyes achieving CDVA of 20/25 or better. DCIVA was 0.19 logMAR, with 66.7% of the eyes achieving 20/30 or better. DCNVA was 0.24 logMAR, with 54.8% of the eyes 20/30 or better. Automated refraction measured with various devices revealed myopic results compared to manifest refraction (-0.24 ± 0.32 D). The mean corneal spherical aberration (4 Conclusion: In vivo wavefront analysis of eyes implanted with this enhanced monofocal IOL suggests that the IOL's positive asphericity profile incremented the pre-existing corneal aberrations, leading to useful intermediate and near vision while maintaining distance-corrected visual acuity better than 20/25 in all eyes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.